Pdp (815)
Duloxetine
Product Images NDC 45865-815
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Duloxetine (NDC 45865-815). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Medsource Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Chemical Structure (Duloxetine 01)
Figure 1 (Duloxetine 02)
Figure 2 (Duloxetine 03)
This is a graph showing the proportion of patients who experienced a relapse while taking a placebo or duloxetine over a period of time. The x-axis represents the time from randomization to relapse in days, while the y-axis represents the proportion of patients experiencing relapse.*
Figure 3 (Duloxetine 04)
Figure 4 (Duloxetine 05)
Figure 7 (Duloxetine 06)
This is a chart that shows the percentage of patients improved in terms of pain relief. The x-axis shows the range of percentage improvement from 0 to 100 while the y-axis represents the treatment groups, one being the placebo while the other is DUL 601120 mg taken once daily. The chart shows that DUL was more effective in improving pain than the placebo.*
Figure 8 (Duloxetine 07)
This is a chart that shows the percentage of patients improved. The top row indicates a 100% improvement. The second row shows the percentage of improvement for both the placebo group and the group that received a 60mg daily dose of DUL. The remaining rows list numerical values for each subgroup. The chart also includes a section that shows the percentage improvement in pain from baseline, but it is not clear what the units of measurement or the source of the data are.*
Figure 9 (Duloxetine 08)
This table provides information about the percentage of patients with improved pain relief based on a base case. The percentage of improvement ranges from 0 to 100, with the highest percentage of improvement observed for patients using DUL 60/120 mg once daily. The table measures percentage improvement in pain from the baseline (BOCF).*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
